GlaxoSmithKline makes bold move with £130m Covid-19 investment | Nils Pratley

Switzerland Nachrichten Nachrichten

GlaxoSmithKline makes bold move with £130m Covid-19 investment | Nils Pratley
Switzerland Neuesten Nachrichten,Switzerland Schlagzeilen

GSK’s share price has been left standing by AstraZeneca’s high-risk success in cancer treatments

Monday’s most important vaccine news was the promising early data from the Oxford University and AstraZeneca coronavirus trial – “robust immune responses” is encouraging. But let’s not overlook other vaccine developments. The industry has been viewed for years as a dull subsector of the pharmaceutical business; now it is a whir of deal-making activity.

 

Bold? With Lord Backsheesh Of Durham At Barnham Castle?

Fuck your poison dart. We know the shite that is in it. The people are waking up!

Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen



Render Time: 2025-01-10 00:14:24